AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2003 FEB 13 - (NewsRx.com & NewsRx.net) -- Millenium Biologix, Inc., a Canadian medical biotechnology company specializing in skeletal repair and tissue engineering, announced that a second series of bone cell research experiments from Canada and Europe will be flown on two of Millenium's "Osteoporosis Experiments in Orbit" (OSTEO) payloads aboard the NASA Shuttle Columbia mission, STS-107, scheduled for launch on January 16, 2003.
Osteoporosis-like bone loss is a serious problem for astronauts during space flight.
To find a solution to this condition, Millenium Biologix, in partnership with the Canadian Space Agency (CSA), developed the OSTEO Mini-Lab System to conduct bone cell research in microgravity. In addition to providing valuable research opportunities in microgravity using the company's Skelite technology, OSTEO forms the foundation for the company's advanced clinical tissue engineering systems. Millenium plans to make these innovative products available to hospitals and clinics around the ...
Source: HighBeam Research, Bone research experiments to be conducted aboard shuttle.(Brief...